Mercedes Tuin

Director Life Sciences & MedTech at Brabantse Ontwikkelings Maatschappij (BOM)

Investment Director Life Sciences & MedTech
2023 - Current
With a team of 6 people we invest in start-ups and scale-ups developing innovative therapeutics, diagnostics, medical devices and healthcare solutions.
Sr Investment Manager Life Sciences-MedTech & Strategy Theme lead Healthy Future
2019 - 2023
BOM Brabant Ventures is a Venture Capital investor realising impact in Noord Brabant enabling start-ups and scale-ups to grow. De BOM investeert in schaalbare start- en scale ups met groeipotentie en een sterke link met Noord-Brabant. BOM Brabant Ventures portfolio includes Acerta Pharma, Atro Medical, BioConnection, BioNovion (Aduro), Cytomate, Cytura, DegenRx, Glycostem, RiboPro, , IME Technologies, Innatoss, InProcessLSP, Lead Pharma, Cristal Therapeutics, Medeye, NTRC, Preceyes, Salvia, SamanTree Medicsl, Synaffix, Ventinova and DegenRx.
Investment Manager Life Sciences & Medtech
2018 - 2019